$3.33
-0.11-3.2%
al cierre: Aug 18, 5:00 PM EST
$3.31
-0.13-3.67%
Premercado: 3:00 AM EST
NRX Pharmaceuticals Inc
NRXPNASDAQ
Ganancias: Los beneficios de Q2 2026 se publicaron el lun ago 17th, antes de la apertura del mercado
Conferencia telefónica: La conferencia telefónica más reciente comenzó a las 4:30 p. m., hace 3 díasHaz clic para ver el webcast
NRX Pharmaceuticals Earnings & Forecasts
NRX Pharmaceuticals (NRXP) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
NRX Pharmaceuticals Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.12 | $-0.10 | $-0.08 | $-0.05 |
| Actual | $-0.44 | $-0.04 | $0.20 | $-0.27 |
| Surprise | -266.7% | +60.0% | +350.0% | -440.0% |
| Revenue | ||||
| Estimate | $1.5M | $22.9M | $7.0M | $10.8M |
| Actual | $1.1M | $1.1M | $983000 | $242000 |
| Surprise | -28.7% | -95.3% | -86.0% | -97.8% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.08 | $-0.03 | $0.07 | $0.07 |
| Revenue | ||||
| Consensus | $2.1M | $8.0M | — | — |